Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 3 (2006), Issue 5 (May)

1. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.
   J Clin Invest, 116(5): 1317-26. [Abstract] [Full-text]
2. "Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.
   J Clin Invest, 116(5): 1254-63. [Abstract] [Full-text]
3. MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.
   Neurology, 66(9): 1384-9. [Abstract] [Full-text]
4. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
   Neurology, 66(9): 1373-83. [Abstract] [Full-text]
5. Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis.
   Urology, 67(5): 960-4. [Abstract] [Full-text]
6. Positional nystagmus and vertigo due to a solitary brachium conjunctivum plaque.
   J Neurol Neurosurg Psychiatry, 77(6): 790-2. [Abstract] [Full-text]
7. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.
   J Neurol Neurosurg Psychiatry, 77(6): 739-42. [Abstract] [Full-text]
8. Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis.
   Neurology, 66(10): 1568-70. [Abstract] [Full-text]
9. Revised diagnostic criteria for neuromyelitis optica.
   Neurology, 66(10): 1485-9. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.